OTX2 represses myogenic and neuronal differentiation in medulloblastoma cells

Cancer Research

Volumn 72, Issue 22, 2012, Pages 5988-6001

  Bai, Ren Yuan ^a   Staedtke, Verena ^a   Lidov, Hart G ^b   Eberhart, Charles G ^a   Riggins, Gregory J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOD1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE REPRESSION; GENE SILENCING; HOMEOBOX; IN VITRO STUDY; MEDULLOBLASTOMA; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; ONCOGENE; ORTHODENTICLE HOMEOBOX 2 GENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; RNA INTERFERENCE; TRANSCRIPTION REGULATION;

ANIMALS; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CERCOPITHECUS AETHIOPS; COS CELLS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; MEDULLOBLASTOMA; MICE; MICE, NUDE; MUSCLE CELLS; MYOD PROTEIN; NEURONS; OTX TRANSCRIPTION FACTORS; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84869219583     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-0614     Document Type: Article

References (50)

1. Klesse LJ, Bowers DC. Childhood medulloblastoma: current status of biology and treatment. CNS Drugs 2010;24:285-301.
2. Eberhart CG. Molecular diagnostics in embryonal brain tumors. Brain Pathol 2011;21:96-104.
3. Helton KJ, Fouladi M, Boop FA, Perry A, Dalton J, Kun L, et al. Medullomyoblastoma: a radiographic and clinicopathologic analysis of six cases and review of the literature. Cancer 2004;101:1445-54.
4. Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, Eden C, et al. Subtypes of medulloblastoma have distinct developmental origins. Nature 2010;468:1095-9.
5. Adamson DC, Shi Q, Wortham M, Northcott PA, Di C, Duncan CG, et al. OTX2 is critical for the maintenance and progression of Shh-independent medulloblastomas. Cancer Res 2010;70:181-91.
6. Simeone A. Otx1 and Otx2 in the development and evolution of the mammalian brain. EMBO J 1998;17:6790-8.
7. Frantz GD, Weimann JM, Levin ME, McConnell SK. Otx1 and Otx2 define layers and regions in developing cerebral cortex and cerebellum. J Neurosci 1994;14:5725-40.
8. Rath MF, Munoz E, Ganguly S, Morin F, Shi Q, Klein DC, et al. Expression of the Otx2 homeobox gene in the developing mammalian brain: embryonic and adult expression in the pineal gland. J Neurochem 2006;97:556-66.
9. Di Salvio M, Di Giovannantonio LG, Omodei D, Acampora D, Simeone A. Otx2 expression is restricted to dopaminergic neurons of the ventral tegmental area in the adult brain. Int J Dev Biol 2010;54:939-45.
10. Simeone A, Di Salvio M, Di Giovannantonio LG, Acampora D, Omodei D, Tomasetti C. The role of otx2 in adult mesencephalic-diencephalic dopaminergic neurons. Mol Neurobiol 2011;43:107-13.
11. Puelles E, Annino A, Tuorto F, Usiello A, Acampora D, Czerny T, et al. Otx2 regulates the extent, identity and fate of neuronal progenitor domains in the ventral midbrain. Development 2004;131:2037-48.
12. Puelles E, Acampora D, Gogoi R, Tuorto F, Papalia A, Guillemot F, et al. Otx2 controls identity and fate of glutamatergic progenitors of the thalamus by repressing GABAergic differentiation. J Neurosci 2006;26:5955-64.
13. Boon K, Eberhart CG, Riggins GJ. Genomic amplification of orthodenticle homologue 2 in medulloblastomas. Cancer Res 2005;65:703-7.
14. Northcott PA, Nakahara Y, Wu X, Feuk L, Ellison DW, Croul S, et al. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet 2009;41:465-72.
15. Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, et al. The genetic landscape of the childhood cancer medulloblastoma. Science 2011;331:435-9.
16. Di C, Liao S, Adamson DC, Parrett TJ, Broderick DK, Shi Q, et al. Identification of OTX2 as a medulloblastomaoncogene whose product can be targeted by all-trans retinoic acid. Cancer Res 2005;65:919-24.
17. de Haas T, Oussoren E, Grajkowska W, Perek-Polnik M, Popovic M, Zadravec-Zaletel L, et al. OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas. J Neuropathol Exp Neurol 2006;65:176-86.
18. Wortham M, Jin G, Sun JL, Bigner DD, He Y, Yan H. Aberrant Otx2 expression enhances migration and induces ectopic proliferation of hindbrain neuronal progenitor cells. PLoS One 2012;7:e36211.
19. Bai R, Siu IM, Tyler BM, Staedtke V, Gallia GL, Riggins GJ. Evaluation of retinoic acid therapy for OTX2-positive medulloblastomas. Neuro Oncol 2010;12:655-63.
20. Bunt J, de Haas TG, Hasselt NE, Zwijnenburg DA, Koster J, Versteeg R, et al. Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines. Mol Cancer Res 2010;8:1344-57.
21. Bunt J, Hasselt NE, Zwijnenburg DA, Hamdi M, Koster J, Versteeg R, et al. OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells. Int J Cancer 2012;131:E21-32.
22. Leonard JR, Cai DX, Rivet DJ, Kaufman BA, Park TS, Levy BK, et al. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features. J Neurosurg 2001;95:82-8.
23. Sachdeva MU, Vankalakunti M, Rangan A, Radotra BD, Chhabra R, Vasishta RK. The role of immunohistochemistry in medullomyoblastoma-a case series highlighting divergent differentiation. Diagn Pathol 2008;3:18.
24. Bergmann M, Pietsch T, Herms J, Janus J, Spaar HJ, Terwey B. Medullomyoblastoma: a histological, immunohistochemical, ultrastructural and molecular genetic study. Acta Neuropathol 1998;95:205-12.
25. Kido M, Ueno M, Onodera M, Matsumoto K, Imai T, Haba R, et al. Medulloblastoma with myogenic differentiation showing double immunopositivity for synaptophysin and myoglobin. Pathol Int 2009;59:255-60.
26. Friedman HS, Burger PC, Bigner SH, Trojanowski JQ, Wikstrand CJ, Halperin EC, et al. Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 Med. J Neuropathol Exp Neurol 1985;44:592-605.
27. Pietsch T, Scharmann T, Fonatsch C, Schmidt D, Ockler R, Freihoff D, et al. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system. Cancer Res 1994;54:3278-87.
28. Chatelain G, Fossat N, Brun G, Lamonerie T. Molecular dissection reveals decreased activity and not dominant negative effect in human OTX2 mutants. J Mol Med 2006;84:604-15.
29. Goldhamer DJ, Brunk BP, Faerman A, King A, Shani M, Emerson CP Jr. Embryonic activation of the myoD gene is regulated by a highly conserved distal control element. Development 1995;121:637-49.
30. Li L, Suzuki T, Mori N, Greengard P. Identification of a functional silencer element involved in neuron-specific expression of the synapsin I gene. Proc Natl Acad Sci U S A 1993;90:1460-4.
31. Bai RY, Dieter P, Peschel C, Morris SW, Duyster J. Nucleophos-min- anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity. Mol Cell Biol 1998;18:6951-61.
32. Wehle D, Yonescu R, Long PP, Gala N, Epstein J, Griffin CA. Fluorescence in situ hybridization of 12p in germ cell tumors using a bacterial artificial chromosome clone 12p probe on paraffin-embedded tissue: clinical test validation. Cancer Genet Cytogenet 2008;183:99-104.
33. Nolen LD, Amor D, Haywood A, St Heaps L, Willcock C, Mihelec M, et al. Deletion at 14q22-23 indicates a contiguous gene syndrome comprising anophthalmia, pituitary hypoplasia, and ear anomalies.Am J Med Genet A 2006;140:1711-8.
34. Tapscott SJ. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development 2005;132:2685-95.
35. Ballas N, Grunseich C, Lu DD, Speh JC, Mandel G. REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell 2005;121:645-57.
36. Chen ZF, Paquette AJ, Anderson DJ. NRSF/REST is required in vivo for repression of multiple neuronal target genes during embryogenesis. Nat Genet 1998;20:136-42.
37. Asakura A, Lyons GE, Tapscott SJ. The regulation of MyoD gene expression: conserved elements mediate expression in embryonic axial muscle. Dev Biol 1995;171:386-98.
38. Yamamoto M, Watt CD, Schmidt RJ, Kuscuoglu U, Miesfeld RL, Goldhamer DJ. Cloning and characterization of a novel MyoD enhanc-er-binding factor. Mech Dev 2007;124:715-28.
39. Lee H, Habas R, Abate-Shen C.MSX1 cooperates with histone H1b for inhibition of transcription and myogenesis. Science 2004;304:1675-8.
40. Carey M, Kakidani H, Leatherwood J, Mostashari F, Ptashne M. An amino-terminal fragment of GAL4 binds DNA as a dimer. J Mol Biol 1989;209:423-32.
41. Bergstrom DA, Tapscott SJ. Molecular distinction between specification and differentiation in the myogenic basic helix-loop-helix transcription factor family. Mol Cell Biol 2001;21:2404-12.
42. Ballas N, Battaglioli E, Atouf F, Andres ME, Chenoweth J, Anderson ME, et al. Regulation of neuronal traits by a novel transcriptional complex. Neuron 2001;31:353-65.
43. Schoenherr CJ, Paquette AJ, Anderson DJ. Identification of potential target genes for the neuron-restrictive silencer factor. Proc Natl Acad Sci U S A 1996;93:9881-6.
44. Palmer SL, Reddick WE, Gajjar A. Understanding the cognitive impact on children who are treated for medulloblastoma. J Pediatr Psychol 2007;32:1040-9.
45. Galli R, Borello U, Gritti A, Minasi MG, Bjornson C, Coletta M, et al. Skeletal myogenic potential of human and mouse neural stem cells. Nat Neurosci 2000;3:986-91.
46. Fife RS, Sledge GW Jr, Roth BJ, Proctor C. Effects of doxycycline on human prostate cancer cells in vitro. Cancer Lett 1998;127:37-41.
47. Onoda T, Ono T, Dhar DK, Yamanoi A, Nagasue N. Tetracycline analogues (doxycycline and COL-3) induce caspase-dependent and -independent apoptosis in human colon cancer cells. Int J Cancer 2006;118:1309-15.
48. Omodei D, Acampora D, Mancuso P, Prakash N, Di Giovannantonio LG, Wurst W, et al. Anterior-posterior graded response to Otx2 controls proliferation and differentiation of dopaminergic progenitors in the ventral mesencephalon. Development 2008;135:3459-70.
49. Heimbucher T, Murko C, Bajoghli B, Aghaallaei N, Huber A, Stebegg R, et al. Gbx2 and Otx2 interact with the WD40 domain of Groucho/Tle corepressors. Mol Cell Biol 2007;27:340-51.
50. Agoston Z, Schulte D. Meis2 competes with the Groucho co-repressor Tle4 for binding to Otx2 and specifies tectal fate without induction of a secondary midbrain-hindbrain boundary organizer. Development 2009;136:3311-22.